Prelude Therapeutics Inc (PRLD) — Financial Flexibility Index
Prelude Therapeutics Inc (PRLD) has a Financial Flexibility Index of -0.53x as of September 2025. Free cash flow of $-19.11 Million (operating CF $-19.11 Million minus capex $0.00) represents -1% of total liabilities ($36.22 Million). Check PRLD tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Prelude Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Prelude Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see Prelude Therapeutics Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Prelude Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Prelude Therapeutics Inc. Explore debt repayment capacity of Prelude Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.32x | $-102.12 Million | $-102.89 Million | $44.06 Million | ▲ +9.2% |
| 2023 | -2.55x | $-103.55 Million | $-107.06 Million | $40.58 Million | ▲ +20.8% |
| 2022 | -3.22x | $-80.71 Million | $-83.73 Million | $25.06 Million | ▲ +23.9% |
| 2021 | -4.23x | $-81.21 Million | $-83.53 Million | $19.20 Million | ▼ -5.9% |
| 2020 | -3.99x | $-45.56 Million | $-46.18 Million | $11.41 Million | ▼ -1044.0% |
| 2019 | -0.35x | $-24.89 Million | $-25.66 Million | $71.28 Million | ▼ -9.9% |
| 2018 | -0.32x | $-12.43 Million | $-12.95 Million | $39.10 Million | — |